Related donor hematopoietic stem cell transplantation for Fanconi anemia without radiation: A single center experience in Turkey

Pediatric Transplantation

Volumn 13, Issue 1, 2009, Pages 88-95

  Ertem, Mehmet ^a   Ileri, Talia ^a   Azik, Fatih ^a   Uysal, Zumrut ^a   Gozdasoglu, Sevgi ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Conditioning regimen; Fanconi anemia; Fludarabine; Non irradiation; Related donor; Stem cell transplantation

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; IMMUNOGLOBULIN; METHOTREXATE; THYMOCYTE ANTIBODY;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FANCONI ANEMIA; FEMALE; FOLLOW UP; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; IRRADIATION; MALE; ORGAN DONOR; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; SCHOOL CHILD; TURKEY (REPUBLIC);

ADOLESCENT; ANTIBIOTIC PROPHYLAXIS; CHILD; FANCONI ANEMIA; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; TRANSPLANTATION CONDITIONING; TURKEY;

EID: 58149287910     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2008.00952.x     Document Type: Article

References (45)

1. Bagby GC, Alter BP. Fanconi anemia. Semin Hematol 2006 : 43 : 147 156.
2. Alter BP. Inherited bone marrow failure syndromes. In : Nathan DG, Orkin SH, Look AT, Ginsburg D, eds. Hematology of Infancy and Childhood. Philadelphia, PA : WB Saunders, 2003 : pp. 280 365.
3. Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood 2003 : 101 : 822 826.
4. Rosenberg PS, Huang Y, Alter BP. Individualized risks of first adverse events in patients with Fanconi anemia. Blood 2004 : 104 : 350 355.
5. Berger R, Bernheim A, Gluckman E, Gisselbrecht C. In vitro effect of cyclophosphamide metabolites on chromosomes of Fanconi anemia patients. Br J Haematol 1980 : 45 : 565 568.
6. Gluckman E, Devergie A, Schaison G, et al. Bone marrow transplantation in Fanconi anemia. Br J Haematol 1980 : 45 : 557 564.
7. Flowers ME, Doney KC, Storb R, et al. Marrow transplantation for Fanconi anemia with or without leukemic transformation: An update of the Seattle experience. Bone Marrow Transplant 1992 : 9 : 167 173.
8. Socie G, Devergie A, Girinski T, et al. Transplantation for Fanconi's anaemia: Long-term follow up of fifty patients transplanted from a sibling donor after low-dose cyclophosphamide and thoraco-abdominal irradiation for conditioning. Br J Haematol 1998 : 103 : 249 255.
9. Di Bartolomeo O, Di Girolamo G, Angrilli F, et al. Allogeneic bone marrow transplantation for Fanconi anemia. Bone Marrow Transplant 1992 : 10 : 53 56.
10. Gluckman E, Auerbach AD, Horowitz MM, et al. Bone marrow transplantation for fanconi anemia. Blood 1995 : 86 : 2856 2862.
11. Guardiola P, Socie G, Pasquini R, et al. Allogeneic stem cell transplantation for fanconi anemia. Severe Aplastic Anaemia Working Party of the EBMT and EUFAR. European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1998 : 21 : S24 S27.
12. Hows JM, Chapple M, Marsh JC, et al. Bone marrow transplantation for Fanconi's anemia: The Hammersmith experience 1977-89. Bone Marrow Transplant 1989 : 4 : 629 634.
13. Kohli-Kumar M, Morris C, Delaat C, et al. Bone marrow transplantation in Fanconi anemia using matched sibling donors. Blood 1994 : 84 : 2050 2054.
14. Zanis-Neto J, Ribeiro RC, Medeiros C, et al. Bone marrow transplantation for patients with Fanconi anemia. A study of 24 cases from a single institution. Bone Marrow Transplant 1995 : 15 : 293 298.
15. Medeiros C, Zanis-Neto J, Pasquini R. Bone marrow transplantation for patients with Fanconi anemia: Reduced doses of cyclophosphamide without irradiation as conditioning. Bone Marrow Transplant 1999 : 24 : 849 852.
16. Deeg HJ, Socie G, Schoch G, et al. Malignancies after bone marrow transplantation for aplastic anemia and Fanconi anemia: A joint Seattle and Paris analysis of results in 700 patients. Blood 1996 : 87 : 386 392.
17. Curtis RE, Rowlings PA, Deeg HJ, et al. Solid cancers after bone marrow transplantation. N Engl J Med 1997 : 336 : 897 904.
18. Witherspoon RP, Fisher LD, Schoch G, et al. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med 1989 : 321 : 784 789.
19. Socie G, Henry-Amar M, Bacigalupo A, et al. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party. N Engl J Med 1993 : 329 : 1152 1157.
20. Bhatia S, Ramsay NK, Steinbuch M, et al. Malignant neoplasms following bone marrow transplantation. Blood 1996 : 87 : 3633 3639.
21. Socie G, Curtis RE, Deeg HJ, et al. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol 2000 : 18 : 348 357.
22. Ades L, Mary JY, Robin M, et al. Long-term outcome after bone marrow transplantation for severe aplastic anemia. Blood 2004 : 103 : 2490 2497.
23. Rosenberg PS, Socie G, Alter BP, Gluckman E. Risk of head and neck squamous cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood 2005 : 105 : 67 73.
24. Guardiola P, Socie G, Li X, et al. Acute graft-versus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA-identical sibling donors: Risk factors and influence on outcome. Blood 2004 : 103 : 73 77.
25. Kapelushnik J, Or R, Slavin S, Nagler A. A fludarabine-based protocol for bone marrow transplantation in Fanconi's anemia. Bone Marrow Transplant 1997 : 20 : 1109 1110.
26. Aker M, Varadi G, Slavin S, Nagler A. A fludarabine-based protocol for human umbilical cord blood transplant in Fanconi's anemia. J Pediatr Hematol Oncol 1999 : 21 : 237 239.
27. de la Fuente J, Reiss S, Mccloy M, et al. Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors. Bone Marrow Transplant 2003 : 32 : 653 656.
28. Maschan AA, Trakhtman PE, Balashov DN, et al. Fludarabine, low-dose busulfan and antithymocyte globulin as conditioning for Fanconi anemia patients receiving bone marrow transplantation from HLA-compatible related donors. Bone Marrow Transplant 2004 : 34 : 305 307.
29. Bitan M, Or R, Shapira MY, Aker M, et al. Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donors. Biol Blood Marrow Transplant 2006 : 12 : 712 718.
30. Tan PL, Wagner JE, Auerbach AD, Defor TE, Slungaard A, Macmillan ML. Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation. Pediatr Blood Cancer 2006 : 46 : 630 636.
31. Torjemane L, Ladeb S, Ben Othman T, Abdelkefi A, Lakhal A, Ben Abdeladhim A. Bone marrow transplantation from matched related donors for patients with Fanconi anemia using low-dose busulfan and cyclophosphamide as conditioning. Pediatr Blood Cancer 2005 : 46 : 496 500.
32. Motwani J, Lawson SE, Darbyshire PJ. Successful HSCT using nonradiotherapy-based conditioning regimens and alternative donors in patients with Fanconi anaemia- Experience in a single UK centre. Bone Marrow Transplant 2005 : 36 : 405 410.
33. Kapelushnik M, Al-Jefri A, Al-Mahr M, et al. Stem cell transplantation for patients with Fanconi anemia with low-dose cyclophosphamide and antithymocyte globulins without the use of radiation therapy. Bone Marrow Transplant 2005 : 35 : 463 466.
34. Guardiola P, Pasquini R, Dokal I, et al. Outcome of 69 allogeneic stem cell transplantation for Fanconi anemia using HLA matched unrelated donors: A study on behalf of the European group for blood and marrow transplantation. Blood 2000 : 95 : 422 429.
35. Nakamura R, Cortez K, Solomon S, et al. High-dose acyclovir and pre-emptive gancyclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantation. Bone Marrow Transplant 2002 : 30 : 235 242.
36. Lawler M, Humphries P, McCann SR. Evaluation of mixed chimerism by in-vitro amplification of dinucleotide repeats sequence using the polymerase chain reaction. Blood 1991 : 77 : 2504 2514.
37. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft versus host diseases in human recipients of marrow from HLA matched sibling donors. Transplantation 1974 : 18 : 295 304.
38. National Cancer Institute (NIC). Common Toxicity Criteria. Epicenter Software. Pasadena, California : National Institute of Health, 1998.
39. Bearman SI, Appelbaum FR, Buckner CD, et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 1988 : 6 : 1562 1568.
40. Ertem M, Kurekci E, Aysev D, Unal E, Ikinciogullari A. Brucellosis transmitted by bone marrow transplantation. Bone Marrow Transplant 2000 : 26 : 225 226.
41. Locatelli F, Bruno B, Zecca M, et al. Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: Results of a GITMO/EBMT randomized trial. Blood 2000 : 96 : 1690 1697.
42. Farzin A, Davies SM, Smith FO, et al. Matched sibling donor haematopoietic stem cell transplantation in Fanconi anaemia: An update of the Cincinnati children's experience. Br J Haematol 2007 : 136 : 633 640.
43. Doney K, Leisenring W, Storb R, Appelbaum FR. Primary treatment of acquired aplastic anemia: Outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team. Ann Intern Med 1997 : 126 : 107 115.
44. Kutler DI, Auerbach AD, Satagopan J, et al. High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. Arch Otolaryngol Head and Neck Surg 2003 : 129 : 106 112.
45. Tezcan I, Tuncer M, Uckan D, et al. Allogeneic bone marrow transplantation in Fanconi anemia from Turkey: A report of four cases. Pediatr Transplant 1998 : 2 : 236 239.